sōna

Coccidioides Antibody Lateral Flow Assay

Coccidioidomycosis, commonly known as Valley Fever, is a challenging condition to diagnose due to limited awareness and its symptoms mimicking other respiratory infections. For those searching for a reliable Coccidioides Valley Fever diagnostic test, early and accurate detection is critical for effective treatment. Valley Fever is said to cause nearly 30% of all community-acquired pneumonia (CAP) cases, but only about 20,000 cases are reported each year in the US.¹ IMMY’s simple, rapid LFA allows for better care and stewardship for patients.

IMMY’s lateral flow assay (LFA) is a game-changer in diagnosing Coccidioides infections, offering a fast, user-friendly, and highly sensitive Coccidioides Valley Fever diagnostic test.

1) Valley Fever (Coccidiodomycoisis) Statistics. Updated 2022. https://www.cdc.gov/fungal/diseases/coccidioidomycosis/statistics.html

Product Documents

Coccidioides Valley Fever diagnostic test

Specimen Types & Registrations

FDA: Serum & CSF

Product Reference & Storage Conditions

CTA2003
2-25°C (Room temperature)

Detect Early. Treat Fast. Save Lives.

Features & Benefits

Save Time

Results in just 30 MINUTES

Accurate

Highly sensitive & specific

Test More Often

Bring testing in-house

Clinical Relevancy ²
SERUM	Positive % Agreement	Negative % Agreement	PPV	NPV
Competitor EIA	93%	99%	94%	99%
Competitor EIA + ID	92%	99%	94%	99%

2) Contreras DA, Li Q, Garner OB. Evaluation of Sona Lateral Flow Assay for the Rapid Detection of Coccidioides Immitis. Poster session presented at: American Society for Microbiology Microbe. 2019 June 20-24; San Francisco, CA

When tested against a competitor's EIA and ID results, the CTA LFA showed high diagnostic performance in 908 serum specimens

The CTA LFA agreed with 93% of the competitor's EIA positive results, and 99% of their negative test results. When compared to both the competitor's EIA and ID results, the CTA LFA agreed with 92% of hteir positive results and 99% of their negative results.